These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 11015748

  • 21. I have severe coronary artery disease and have been receiving chelation therapy. When I mentioned this to my doctor, he said I was wasting my money, and that I ought to stop. What do you think?
    Francis GS.
    Heart Advis; 2002 May; 5(5):8. PubMed ID: 12085836
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Chelation therapy for heart disease.
    JAAPA; 2005 Jan; 18(1):58. PubMed ID: 15675123
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Bound together for health. An introduction to chelation therapy.
    Moscicki HE, Lieberman LL.
    Adv Nurse Pract; 2001 May; 9(5):46-8, 50. PubMed ID: 12400259
    [No Abstract] [Full Text] [Related]

  • 29. Chelation therapy in the treatment of cardiovascular diseases.
    Ibad A, Khalid R, Thompson PD.
    J Clin Lipidol; 2016 May; 10(1):58-62. PubMed ID: 26892121
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. EDTA chelation therapy for atherosclerotic cardiovascular disease.
    Med Lett Drugs Ther; 1994 May 27; 36(923):48. PubMed ID: 8177139
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Chelation Therapy as a Cardiovascular Therapeutic Strategy: the Rationale and the Data in Review.
    Mathew RO, Schulman-Marcus J, Nichols EL, Newman JD, Bangalore S, Farkouh M, Sidhu MS.
    Cardiovasc Drugs Ther; 2017 Dec 27; 31(5-6):619-625. PubMed ID: 29129003
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Design of the Trial to Assess Chelation Therapy (TACT).
    Lamas GA, Goertz C, Boineau R, Mark DB, Rozema T, Nahin RL, Drisko JA, Lee KL.
    Am Heart J; 2012 Jan 27; 163(1):7-12. PubMed ID: 22172430
    [Abstract] [Full Text] [Related]

  • 38. Chelation therapy in cardiovascular disease: an update.
    Sultan S, Murarka S, Jahangir A, Mookadam F, Tajik AJ, Jahangir A.
    Expert Rev Clin Pharmacol; 2017 Aug 27; 10(8):843-854. PubMed ID: 28597699
    [Abstract] [Full Text] [Related]

  • 39. Why the NIH Trial to Assess Chelation Therapy (TACT) should be abandoned.
    Atwood KC, Woeckner E, Baratz RS, Sampson WI.
    Medscape J Med; 2008 May 13; 10(5):115. PubMed ID: 18596934
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.